NEW YORK (GenomeWeb) – Rainbow Genomics said today that it is partnering with Color to provide hereditary cancer and heart health genetic risk assessment tests in Hong Kong. Rainbow, a preferred partner of Color in Hong Kong, will offer that firm's genetic tests for the analysis of a patient's risk for eight hereditary cancers and four hereditary heart health conditions. The partnership, Rainbow said, will provide a fully integrated solution for actionable clinical test results at an affordable price point, though it did not elaborate.
Rainbow Genomics is to offer Californian firm Color Genomics' genetic tests to users in Hong Kong, testing for eight hereditary cancers and four hereditary heart health conditions. The company has already begun offering its services to the public via a beta version of its website that will be launched later this year. The announcement follows Rainbow Genomics' earlier indication that it was looking to partner with US firms to offer genetic testing in Asia.